BRKR: Barclays Raises Target
Barclays maintains overweight rating on Bruker and raises price target to $60
Barclays Maintains Overweight on Bruker, Raises Price Target to $60
Barclays maintains overweight rating on Bruker and raises price target to $60
Barclays Maintains Overweight on Bruker, Raises Price Target to $60